Hair Relaxer Lawsuit Guide

The federal hair relaxer cancer lawsuits are moving forward, with nearly 11,000 cases consolidated in a multidistrict litigation (MDL) before U.S. District Judge Mary Rowland in the Northern District of Illinois.

Plaintiffs claim that manufacturers of chemical hair straighteners, including Dark & Lovely and Just for Me, failed to warn consumers about potential cancer risks.

Their allegations cite scientific studies published about three years ago that link long-term use of these products to uterine, ovarian, and endometrial cancers.

At a September 4 status conference, Judge Rowland set new deadlines for expert evidence.

She extended the plaintiffs’ time for expert disclosures and ordered all expert discovery to close by March 2, 2026.

Challenges to expert testimony under Daubert (Rule 702) must be filed by April 1, 2026.

These motions will determine whether plaintiffs’ experts can present scientifically reliable opinions on the alleged cancer risks.

The results of these hearings will be critical.

If the experts’ testimony is excluded, many claims could be dismissed. If admitted, the litigation will advance to bellwether trials involving 32 representative cases currently in discovery.

While these first trials will not directly decide other claims, their outcomes are expected to strongly influence settlement negotiations and the broader direction of this growing litigation.

The hair relaxer litigation continues to grow, with 10,858 lawsuits pending in the multidistrict litigation (MDL) as of September.

This marks an increase from 10,567 cases in August, adding nearly 300 new filings in one month.

The MDL, centralized in the Northern District of Illinois, involves claims that long-term use of chemical hair relaxer products is linked to uterine cancer, ovarian cancer, and other serious health issues.

Plaintiffs allege that manufacturers failed to provide adequate warnings about these potential risks.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer multidistrict litigation (MDL) grew to 10,567 cases between July and August, rising from 10,404 the previous month.

Plaintiffs continue to file claims alleging that chemical hair straighteners contributed to uterine cancer and other significant health conditions.

Discovery efforts remain underway, with both sides exchanging documents and expert analyses.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

U.S. District Judge Mary Rowland has denied Revlon’s request to subpoena internal documents from the National Institutes of Health (NIH) related to hair relaxer cancer studies.

Revlon sought access to raw data, drafts, work papers, and communications between NIH scientists and plaintiffs’ attorneys in an attempt to challenge the credibility of studies supporting claims in the ongoing hair relaxer multidistrict litigation (MDL).

The court ruled in favor of the NIH, which invoked the deliberative process privilege, protecting its internal discussions and unpublished materials from disclosure.

Judge Rowland agreed, finding that Revlon failed to demonstrate a compelling need for the documents and emphasizing the NIH’s status as a non-party to the litigation.

She also ruled that the possibility of financial harm to Revlon did not outweigh the legal protections afforded to federal agencies.

This decision strengthens the position of plaintiffs in the hair relaxer lawsuits by preserving reliance on peer-reviewed scientific research and limiting discovery attempts that could burden external institutions.

It also signals the court’s resistance to drawing non-party federal agencies into complex litigation without a clear and justified need.

Revlon remains in bankruptcy, having received approval for its Chapter 11 reorganization plan in early 2023.

California state court has centralized a growing number of hair dye bladder cancer lawsuits brought by salon professionals who claim that long-term occupational exposure to professional coloring products caused bladder cancer.

At least 15 cases have been filed, including a lead complaint and over a dozen related claims, all coordinated before a single judge for streamlined pretrial management.

An initial status conference originally set for August was moved up to July 21, 2025, reflecting the court’s urgency in advancing the docket.

Plaintiffs in the hair dye lawsuits allege that professional dye products were marketed as safe, despite evidence that repeated skin contact and inhalation during use significantly increases cancer risk—even when gloves and other precautions are followed.

Decades of cumulative exposure place salon workers, particularly hairdressers and colorists, at elevated risk for bladder cancer.

Defendants named in the lawsuits include major cosmetic companies responsible for professional hair dye brands.

The court is expected to address protective orders, evidence preservation, and the potential structure for early bellwether trials.

The lead case may serve as a test for key legal issues including failure to warn, exposure science, and general causation.

These lawsuits differ from the federal hair relaxer MDL, which focuses on reproductive cancers, but both proceedings involve long-term exposure to salon chemicals and manufacturer liability.

Outcomes in the hair dye litigation may influence legal strategy and discovery standards across related dockets.

A recent peer-reviewed study published in Cancer Epidemiology, Biomarkers & Prevention on July 1 projects that uterine cancer deaths will nearly double by 2050, with Black women facing the steepest rise.

The research estimates a 98% increase in mortality among Black women, with rates expected to reach 27.9 deaths per 100,000—more than double the 11.2 per 100,000 projected for white women.

Researchers attribute the growing disparity to factors such as more aggressive cancer subtypes, delayed diagnoses, and unequal access to healthcare.

While the study does not identify a definitive cause, it highlights hormone-disrupting chemicals—particularly those found in hair relaxers—as a possible contributor.

This supports earlier findings from a 2022 NIEHS study that linked frequent use of hair straighteners to a 2.5-times greater risk of developing uterine cancer. Black women were overrepresented among high-frequency users, though the risk increase was consistent across racial groups.

These findings come as litigation intensifies against cosmetic companies like L’Oréal and SoftSheen-Carson. Plaintiffs allege that these manufacturers failed to adequately warn consumers—many of whom began using relaxers during childhood—about the potential cancer risks linked to prolonged exposure.

The growing number of cases has been consolidated into a federal multidistrict litigation (MDL) in the Northern District of Illinois, where coordinated pretrial proceedings are ongoing.

The federal judge presiding over the expanding multidistrict litigation (MDL) involving hair relaxer products has set January 8, 2026, for a “Science Day” to examine the scientific evidence linking chemical hair straighteners to reproductive cancers.

To date, more than 12,000 lawsuits have been filed, with plaintiffs alleging that long-term use of products like Dark and Lovely, Just for Me, and ORS Olive Oil led to the development of uterine, ovarian, or endometrial cancer.

The suits target major manufacturers such as L’Oréal and Revlon, accusing them of failing to warn consumers—primarily Black women—about the health risks associated with prolonged chemical exposure.

Science Day will provide each side with two hours to deliver non-adversarial presentations on the relevant science.

While these summaries won’t be considered formal evidence and will not involve cross-examination, they are expected to play a critical role in shaping the court’s decisions regarding expert testimony and evidence admissibility moving forward.

This stage of the litigation precedes upcoming bellwether trials, beginning with a pool of 32 selected cases for discovery.

These early trials are intended to help assess how juries respond to the evidence and may serve as a basis for future settlement discussions.

The Hair Relaxer multidistrict litigation (MDL) rose to 10,404 total cases in July, up from 10,317 in June.

While the rate of new filings has slowed, several hundred additional claims continue to be added monthly.

Plaintiffs allege that long-term use of chemical hair straightening products has been linked to serious reproductive health conditions, including uterine cancer, endometriosis, and other hormone-related illnesses.

Discovery efforts are still underway as both sides prepare for upcoming bellwether trials.

If you or a loved one developed cancer or other health complications after using hair relaxers or chemical hair straighteners, you may be eligible to pursue legal action.

Contact TruLaw for a free case evaluation, or use the chatbot on this page to find out instantly if you qualify to file a Hair Relaxer Lawsuit.

The court overseeing the Hair Relaxer multidistrict litigation (MDL) has set Science Day for January 8, 2026.

During this session, both plaintiffs and defendants will have two hours each to present scientific and medical evidence relevant to the litigation.

Judges involved in related state court cases have also been invited to attend the proceedings.

Science Day serves as a key pretrial step, providing the Court with an overview of complex scientific issues before it considers expert witness challenges or pretrial motions.

It remains to be seen whether the litigation will reach Science Day or be resolved beforehand through settlement.

Judge Mary Rowland has removed Walgreens from the multidistrict litigation (MDL) over chemical hair relaxers, dismissing the only case that named the retailer as a defendant.

The lawsuit involved a woman who passed away from uterine cancer and cited a single purchase of hair relaxer products from a Walgreens store in 2010.

However, the complaint failed to provide any evidence that Walgreens knew—or should have known—about potential cancer risks associated with the products.

The court found the allegations too vague and unsupported by factual detail.

Claims for breach of warranty and unjust enrichment were also rejected due to the lack of a direct connection between Walgreens’s conduct and the plaintiff’s alleged injuries.

Attorneys involved in the MDL had already ceased efforts to include Walgreens as a central defendant in the litigation.

The Philadelphia Court of Common Pleas has officially created a mass tort program to manage state-level hair relaxer lawsuits.

Roughly 25 cases have been consolidated into the court’s Complex Litigation Center for coordinated pretrial proceedings.

The program is designed to improve efficiency in handling claims that link chemical hair relaxer products to serious health risks, including hormone-related cancers.

Plaintiffs allege that manufacturers failed to warn about the dangers of long-term exposure to endocrine-disrupting chemicals found in these products.

Philadelphia now joins states like Georgia and New York in organizing similar state-level proceedings.

Meanwhile, the federal hair relaxer multidistrict litigation (MDL No. 3060) remains active in the Northern District of Illinois, where hundreds of related cases are being litigated.

New York State is moving forward with legislation aimed at protecting consumers from the health risks linked to chemical hair relaxers.

On June 5, 2025, the State Senate passed Bill S6723, which would require warning labels on hair relaxer products that contain carcinogens or reproductive toxicants.

The proposed law mandates that product packaging include one of the following clear warnings:

• “This product contains a chemical known to cause cancer”
• “This product contains a chemical known to cause birth defects or other reproductive harm”
• “This product contains chemicals known to cause cancer and birth defects or other reproductive harm”

The warnings must appear in at least 12-point font and be prominently displayed on the label.

The bill gives the New York Attorney General authority to enforce the law, with penalties of up to $250 per unit for a first offense and $500 per unit for any repeat violations.

This legislative effort follows growing concern over the link between long-term hair relaxer use and hormone-related cancers, especially among Black women.

Numerous lawsuits have already been filed against manufacturers, alleging that they failed to warn consumers about these dangers.

If the bill passes the Assembly and is signed into law, it will take effect 18 months later, giving manufacturers time to meet the new requirements.

On June 10, 2025, Judge Mary M. Rowland directed defendants in the Hair Relaxer multidistrict litigation (MDL No. 3060) to select a new bellwether case following the voluntary dismissal of one of the original plaintiffs.

The replacement must be chosen by July 1, 2025.

Judge Rowland confirmed that the bellwether substitution will not impact the current litigation schedule, including expert discovery on general causation, which is set to close in early 2026.

Bellwether trials in this MDL are designed to test claims that chemical hair relaxers cause uterine, endometrial, and ovarian cancers.

Results from these initial trials could shape future settlement negotiations and litigation outcomes.

The MDL, centralized in the Northern District of Illinois, involves thousands of women who allege long-term exposure to hair relaxer products from L’Oréal, SoftSheen-Carson, and others led to hormone-related cancers.

The first trials are expected to begin in late 2026 or early 2027.

The Hair Relaxer MDL grew by 381 cases between May and June, raising the total number of filings to 10,317.

This increase follows continued outreach by firms representing individuals who developed cancer after long-term use of chemical hair straighteners.

Many of the newly filed lawsuits include pathology reports and product use histories that trace exposure back to early childhood.

Plaintiffs are urging the court to expand discovery to additional manufacturers, citing overlapping ingredients and similar exposure timelines across various product lines.

Current case evaluations are focusing on hormone-related cancer diagnoses linked to extended use of these chemical products.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

A newly published peer-reviewed study has intensified concerns about chemical exposure from personal care products, particularly those targeted at Black women and Latinas.

The research found that over half of commonly used items—including shampoos, lotions, and soaps—contained formaldehyde or formaldehyde-releasing preservatives, substances linked to cancer and other serious health risks.

The study, titled Taking Stock, analyzed daily product use among 70 women in South Los Angeles.

It identified DMDM hydantoin as the most prevalent formaldehyde-releasing agent, followed by diazolidinyl urea, imidazolidinyl urea, and quaternium-15.

These chemicals are notoriously difficult to recognize on ingredient labels and remain widely used despite their known toxicity.

These findings echo long-standing warnings from the Environmental Working Group (EWG), which has consistently highlighted that products marketed to Black women disproportionately contain hazardous ingredients.

Formaldehyde exposure is especially concerning in professional salon products like hair relaxers and straighteners, which are now at the center of hundreds of lawsuits.

Plaintiffs in these cases allege that chronic exposure to formaldehyde and hormone-disrupting chemicals has led to uterine and breast cancers, as well as other reproductive health issues.

The new study bolsters these claims, offering further evidence of systemic chemical exposure in marginalized communities.

While states such as California, Maryland, and Washington have enacted bans on formaldehyde in cosmetics, no federal ban currently exists.

Advocacy organizations like the EWG continue to call on the FDA to prohibit formaldehyde in all hair-straightening products, emphasizing the urgent need for nationwide regulation.

A total of 32 lawsuits have been selected to proceed through bellwether discovery in the multidistrict litigation (MDL) concerning chemical hair relaxers.

These cases will serve as a critical test group to guide the handling of more than 12,000 similar claims currently consolidated in federal court.

The selected lawsuits involve women who developed hormone-related cancers allegedly linked to long-term use of widely marketed hair relaxer products such as Dark & Lovely, Just for Me, Optimum, and ORS Olive Oil.

Plaintiffs claim that the manufacturers failed to properly warn users about the potential dangers of endocrine-disrupting chemicals found in these products, which have been heavily promoted to African American consumers for decades.

As part of the bellwether selection process, both plaintiffs and defense teams nominated 20 cases each.

After each side exercised four strikes against the other’s choices, a final list of 32 cases was agreed upon.

These cases will now undergo focused discovery and preparation over the coming two years.

According to a joint status update, fact discovery is scheduled to conclude by February 16, 2026, followed by the close of general causation discovery on March 2, 2026.

Any Daubert motions—legal challenges to the validity of expert testimony—must be filed by May 15, 2026.

U.S. District Judge Mary Rowland is expected to select three bellwether cases for trial by February 23, 2026.

However, based on the current case schedule, the first trial is unlikely to commence before mid-2027.

The Hair Relaxer Lawsuit continues to focus on allegations that long-term use of chemical hair relaxers and straighteners has caused serious health issues, including uterine and breast cancer.

Plaintiffs claim that manufacturers failed to adequately warn consumers—particularly women of color—about the dangers associated with repeated exposure to harmful, endocrine-disrupting chemicals in these products.

As of April 2025, no new cases have been added to the Hair Relaxer multidistrict litigation (MDL), with the total number of filings holding steady at 9,936.

While new additions have temporarily paused, the litigation remains active as discovery progresses and plaintiffs continue to build their cases.

The fight for accountability continues as more women come forward to demand justice for the long-term health consequences tied to these widely marketed hair care products.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer multidistrict litigation (MDL), which currently includes close to 10,000 active claims, is reaching a pivotal stage in its bellwether case selection process.

By early next week, attorneys for both plaintiffs and defendants are expected to submit 20 proposed cases each—bringing the initial bellwether pool to 40.

Following this, each party will have the opportunity to dismiss four cases they consider strategically disadvantageous, resulting in a refined group of 32 cases to undergo in-depth case development.

These selected cases will move through a year-long phase of individualized discovery, including the exchange of expert witness reports, which is projected to wrap up by the end of 2025.

From this group, a final set of 10 bellwether cases will be chosen by early 2026 for trial.

Although this timeline creates a structured pathway toward initial trials, the possibility of reaching a comprehensive settlement this year appears slim, despite cautious optimism from some stakeholders.

The general outlook remains uncertain due to the pace and complexity of the proceedings.

This progression highlights how trial scheduling continues to play a critical role in resolving large-scale tort claims and marks another step forward in the ongoing litigation involving chemical hair straightening products.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit continues to grow, with a modest increase in filings reported between March and April 2025.

In March, there were 9,788 lawsuits pending in the multidistrict litigation.

By April, that number rose to 9,936, reflecting an addition of 148 new cases.

This steady uptick highlights ongoing interest in holding manufacturers accountable for the health risks allegedly linked to chemical hair relaxers.

Plaintiffs claim that prolonged use of these products has led to serious medical conditions, including various forms of cancer.

As awareness increases, more individuals are stepping forward to pursue justice for the harm they believe was caused by long-term product use.

If you or a loved one used hair relaxers or chemical hair straightening products and were subsequently diagnosed with cancer or other related health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a claim instantly.

A Virginia woman has filed a lawsuit against L’Oréal, Revlon, and Softsheen-Carson, alleging that long-term use of chemical hair relaxers led to her diagnoses of uterine and endometrial cancer.

Filed on March 20, 2025, in the U.S. District Court for the Northern District of Illinois, her complaint claims that decades of exposure to products like Optimum Relaxer, Olive Oil Relaxer, and Cream of Nature No Lye Relaxer caused serious reproductive harm.

Her case joins more than 6,500 similar lawsuits now consolidated in a federal multidistrict litigation (MDL) overseen by Judge Mary Rowland in Chicago.

The lawsuits follow a 2022 study by the National Institutes of Health that found a link between chemical hair relaxers and a significantly increased risk of uterine cancer.

Additional studies have also connected these products to endometrial and ovarian cancers.

The plaintiff, like many others, argues that the manufacturers failed to warn consumers—particularly Black women, who were disproportionately targeted in advertising—about the dangers of endocrine-disrupting chemicals used in these products.

Earlier this month, Judge Rowland initiated the bellwether trial selection process.

While the first trials are not expected before 2027, they are expected to shape the trajectory of settlement negotiations moving forward.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

As awareness of the potential health risks tied to chemical hair relaxers continues to grow, more Black women are shifting toward natural hair care alternatives.

A recent report highlights how this movement has been fueled by increasing concern over the link between relaxers and serious health conditions, including uterine cancer and other gynecological tumors.

One veteran hairstylist, with nearly 40 years in the industry, shared her personal experience witnessing the damage relaxers can cause.

After years of treating clients with scalp burns and hair loss, she made the decision in 2010 to eliminate chemical relaxers from her salon entirely—reflecting a broader trend aligned with the natural hair movement.

This cultural and health-conscious shift comes as thousands of women across the U.S. file lawsuits against major hair care companies.

These claims allege that repeated use of hair straightening products caused long-term health problems, particularly for women of color.

The litigation builds on scientific findings like the National Institutes of Environmental Health Sciences’ “Sister Study,” which reported that women who used chemical relaxers more than four times a year had more than double the risk of developing uterine cancer.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

Concerns over the health risks of chemical hair relaxers continue to drive a shift away from these products, as studies increasingly link them to serious health conditions like uterine and ovarian cancers.

For years, Black women were heavily targeted by advertisements for chemical relaxers, many of whom used them to straighten their hair.

Now, thousands of women are involved in a growing legal battle against cosmetic manufacturers, claiming these products caused life-threatening health problems.

The most significant legal development is the creation of a bellwether trial schedule for the multidistrict litigation (MDL) concerning hair relaxers.

The MDL consolidates over 6,500 product liability lawsuits filed by women diagnosed with uterine cancer, ovarian cancer, and endometrial cancer after using chemical relaxers like Optimum, Dark & Lovely, and Just For Me.

These lawsuits claim that endocrine-disrupting chemicals in the relaxers caused these cancers due to long-term use.

The bellwether trials, which aim to assess the potential success of other cases in the MDL, are set to begin in mid-2027.

A recent ruling by U.S. District Judge Mary Rowland details the selection process for 40 potential bellwether cases, all involving women diagnosed with cancers linked to hair relaxer use.

The judge also provided a timeline for discovery and pretrial motions, with the first trials not expected until 2027.

The MDL’s progression follows studies like the “Sister Study,” which found that regular use of chemical relaxers could double the risk of uterine cancer.

As the legal process moves forward, the potential for settlements increases, but the lengthy timeline suggests that many women seeking justice for their health issues may face years of litigation.

If the bellwether trials do not lead to a global settlement, individual trials could begin in various U.S. District Courts, further extending the litigation process.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

A new Hair Relaxer Lawsuit has been filed on behalf of a Mississippi woman who died from endometrial cancer after using chemical hair straighteners for 16 years.

The lawsuit, filed on February 27, 2025, in the U.S. District Court for the Northern District of Illinois, targets major brands such as L’Oreal, Softsheen-Carson, Dabur International, and others.

It claims that exposure to chemicals in products like Just for Me, Dark & Lovely, and ORS Olive Oil caused Swearengen’s fatal cancer.

This lawsuit is part of over 6,500 claims alleging that hair relaxer manufacturers are responsible for uterine, ovarian, and endometrial cancers. 

The lawsuits are based on studies linking these products to cancer risks, with plaintiffs arguing that manufacturers failed to warn consumers about the potential health dangers. 

These cases are now part of a multidistrict litigation (MDL) overseen by Judge Mary Rowland. Bellwether trials focused on uterine, endometrial, and ovarian cancers will help guide the settlement process in the years ahead.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit involves allegations that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers such as uterine and breast cancer.

Plaintiffs claim that manufacturers failed to warn consumers about the long-term health risks associated with these products.

In February, 9,863 Hair Relaxer Lawsuits were pending in the MDL, a number that decreased slightly to 9,788 in March, reflecting a reduction of 75 cases.

This decline may result from case consolidations or procedural changes within the litigation.

Exposure to harmful chemicals in hair relaxers has been associated with serious health conditions, including hormone-related cancers, significantly affecting users’ health.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

A new investigation by Consumer Reports has raised serious safety concerns about synthetic braiding hair, revealing that these products may contain harmful levels of toxic chemicals and heavy metals.

The report analyzed 10 popular brands and found that every product tested contained carcinogens and volatile organic compounds (VOCs), along with lead and other hazardous substances.

Among the most alarming findings: carcinogens like benzene, methylene chloride, and styrene were detected in all samples.

Nine out of ten products contained lead levels that exceeded safe exposure limits.

When heated—such as during styling—these products released VOCs like acetone and toluene, which are known to cause respiratory issues, headaches, and long-term health complications.

Users have also reported adverse skin reactions, including itching, rashes, and irritation.

These findings are particularly concerning for Black women, who are the primary users of synthetic braiding hair.

Experts warn that repeated exposure to these chemicals through the scalp, inhalation, or hand-to-mouth contact could have significant health effects over time.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

Hair stylists and salon professionals are increasingly filing lawsuits against hair dye manufacturers, claiming that the companies failed to provide adequate warnings about the cancer risks associated with long-term exposure to the chemicals found in hair coloring products.

Growing research has revealed that the chemicals in both permanent and semi-permanent hair dyes, as well as temporary dyes, are linked to an increased risk of developing serious conditions such as bladder and breast cancer.

These concerns are further magnified for those who work in salons, as studies show they face a significantly higher risk due to frequent and prolonged exposure to harmful carcinogens.

Chemicals like aromatic amines, formaldehyde, and resorcinol, which are present in many hair dyes, have been identified as particularly dangerous, posing a greater threat to salon workers who regularly come into contact with these substances.

As the evidence grows, the demand for legal accountability and better protective measures for workers in the beauty industry continues to rise.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit is ongoing. 

A former hairstylist has filed a lawsuit against L’Oréal and 10 other beauty companies, claiming that prolonged exposure to carcinogenic chemicals in hair products led to his bladder cancer.

The lawsuit, filed in Los Angeles, alleges that manufacturers failed to warn consumers and professionals about the dangers of chemicals like 4-aminobiphenyl (4-ABP), a known carcinogen still present in some hair dyes and relaxers.

Decades of occupational studies have linked long-term exposure to hair dyes and relaxers to an increased risk of bladder cancer, uterine cancer, and other health conditions among hairstylists and frequent users.

Research has also raised concerns about the risks for women of color, as darker hair dyes and relaxers contain higher levels of harmful chemicals.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer MDL has entered a pivotal phase with both sides beginning to select 40 bellwether cases.

Bellwether trials serve as test cases in multidistrict litigation (MDL), offering insights into how juries might respond to similar lawsuits based on evidence and arguments.

The results of these trials can significantly influence settlement talks and the overall trajectory of the litigation.

Each side will choose 20 cases and submit a joint stipulation to the court by May 9, 2025.

After selection, individual case work will continue until February 2026, followed by a year of expert analysis.

The cancers chosen for these cases will play a critical role in shaping the litigation and identifying the strongest claims.

Given this timeline, a settlement in 2025 seems unlikely as the litigation progresses through discovery and expert evaluation.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

At the start of the year, 9,819 cases were pending in the Hair Relaxer MDL, and by February, the number increased to 9,863, with 44 new claims filed.

The Hair Relaxer Lawsuit centers on allegations that chemicals in hair relaxers and straighteners contain carcinogens linked to cancers, including uterine and breast cancer.

Plaintiffs argue that manufacturers did not warn consumers about the long-term health risks associated with these products.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The proposed FDA ban on formaldehyde in hair relaxer products, linked to increased cancer risks, faces uncertainty due to regulatory freezes under the new presidential administration.

Initially introduced in October 2023, the ban sought to eliminate formaldehyde and its byproducts from hair relaxers sold in the U.S.

Although finalization was expected by April 2024, delays under the prior administration have allowed products containing formaldehyde to remain on the market.

According to NBC News, recent administrative measures, including a pause on new regulations, could further undermine the ban.

Despite this, states such as California, Maryland, and Washington have implemented their own bans on formaldehyde in hair care products.

Formaldehyde, widely used in consumer goods, has been linked to cancers like uterine and ovarian cancer, along with respiratory and reproductive health issues.

Recent lawsuits claim manufacturers, including L’Oréal and Revlon, knowingly sold harmful products, such as Dark & Lovely and Just for Me, which contain endocrine-disrupting chemicals.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit is ongoing. 

The Hair Relaxer Lawsuit remains active, with a new case filed on December 30, 2024, by a Neptune, New Jersey, resident against Strength of Nature, LLC, and Godrej SON Holdings, Inc.

The lawsuit, filed in the U.S. District Court for the Northern District of Illinois, alleges that the prolonged use of the defendants’ hair relaxer products caused the plaintiff to develop uterine cancer, diagnosed in July 2016.

This case is part of MDL No. 3060, a consolidated litigation that includes numerous claims asserting that hair relaxer manufacturers failed to warn consumers about the cancer risks associated with their products.

The plaintiff contends that the products were defectively designed and contained dangerous chemicals linked to cancer.

Claims in the lawsuit include:

• Negligence
• Strict Liability: Design Defects and Failure to Warn
• Breach of Warranties: Under State Law and the Magnuson-Moss Warranty Act
• Fraudulent Misrepresentation and Concealment
• Violation of Consumer Protection Laws

The plaintiff specifically identified the African Pride Olive Miracle Deep Conditioning No-Lye Relaxer as one of the products she used.

She alleges that the manufacturers failed to provide adequate warnings about the risks or develop safer alternatives, despite being aware of the potential harm.

The plaintiff is seeking compensatory damages for her injuries, medical expenses, and suffering, as well as punitive damages to hold the manufacturers accountable and prevent future misconduct.

This case, assigned Case ID: 1:24-cv-13330, will be presided over by Judge Mary M. Rowland in the Northern District of Illinois.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit involves allegations that the chemicals in hair relaxers and straighteners contain carcinogens, which have been linked to cancers such as uterine and breast cancer.

Plaintiffs argue that manufacturers failed to warn consumers, especially women of color, about the long-term health risks associated with these products.

In December 2024, 9,649 cases were pending in the Hair Relaxer MDL.

By January 2025, the number of cases had increased to 9,819, with 170 new claims added.

This rise in cases reflects growing awareness of the potential dangers linked to the prolonged use of these products.

Exposure to harmful chemicals in hair relaxers has been connected to serious health risks, including hormone-related cancers, which pose significant dangers to users.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

New research published in the European Journal of Obstetrics and Gynaecology and Reproductive Biology raises concerns about the harmful effects of chemicals in hair products, including dyes and chemical straighteners.

The 2024 study highlights possible links between these products and hormonal disruptions, as well as increased cancer risks, particularly with breast and ovarian cancers associated with hair relaxers and dyes.

Chemicals like aromatic amines, parabens, formaldehyde, resorcinol, and ammonia are identified as key culprits.

These substances can interfere with hormonal systems, mimic estrogen, and increase the risk of long-term health issues, including cancer.

Formaldehyde, frequently found in chemical straighteners, is especially concerning due to its carcinogenic properties.

As lawsuits related to hair relaxers continue, this study emphasizes the need for greater consumer awareness and industry accountability.

Plaintiffs in ongoing Hair Relaxer litigation assert that manufacturers failed to warn about these risks, despite clear evidence of harmful chemical exposure through the scalp.

This study may strengthen claims in current lawsuits, highlighting the health risks these products pose.

As cases progress, the findings could have major implications for consumer safety regulations and product liability standards.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

Lawyers involved in the federal hair relaxer lawsuits have been unable to reach a consensus on the bellwether trial process.

On December 13, U.S. District Judge Mary Rowland directed both parties to submit competing proposals by January 3, 2025.

This decision affects nearly 10,000 lawsuits centralized in the Northern District of Illinois as part of multidistrict litigation (MDL).

The lawsuits claim that well-known hair relaxer brands, such as Dark & Lovely and Just For Me, did not adequately warn consumers about the cancer risks associated with their products.

Research published in 2022 indicated that women using these products faced a significantly higher risk of uterine cancer and other health issues linked to endocrine-disrupting chemicals.

Judge Rowland is working to implement a “bellwether” process, selecting 16 representative cases to move forward to trial.

These trials will evaluate common legal arguments and evidence, potentially shaping future settlement negotiations.

The plaintiffs contend that delays in selecting the bellwether cases are due to the defendants’ failure to finalize their eight case selections, despite having had ample time to review the required documents.

The court plans to issue a detailed bellwether protocol that will address trial selection, discovery schedules, and case preparations.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Cancer lawsuit alleges that chemicals in hair relaxers and straighteners contain carcinogens associated with cancers, including uterine and breast cancer.

Plaintiffs claim that manufacturers failed to warn consumers, particularly women of color, about the risks of long-term use.

In November, 9,488 cases were filed, increasing to 9,639 in December with 151 additional claims.

Prolonged exposure to these chemicals has been linked to hormone-related cancers, leading to serious health challenges for those affected.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The number of lawsuits involving hair relaxers continues to grow, with nearly 9,500 cases in federal courts and an additional 300 lawsuits filed in state courts across Illinois, Georgia, New York, Pennsylvania, and Delaware.

Most federal Hair Relaxer Lawsuits are consolidated under multidistrict litigation (MDL) in the Northern District of Illinois, overseen by Judge Mary Rowland.

Plaintiffs allege that toxic chemicals in popular products like Dark & Lovely, Just for Me, Optimum Care, and ORS Olive Oil have caused uterine cancer, endometrial cancer, ovarian cancer, and other injuries.

Federal litigation updates:

• Status Conference: Judge Rowland recently addressed key issues, including motions to dismiss, deposition protocols, and the selection process for bellwether trials.
• Discovery Phase: Evidence sharing for common claims is ongoing and expected to continue through late 2025.
• Bellwether Trials: Early trials will test jury responses to evidence, which could help shape future settlement discussions.
• Dismissals Without Prejudice: Claims involving injuries other than uterine, endometrial, or ovarian cancer were dismissed without prejudice, allowing plaintiffs to refile if one of these cancers develops.

State court developments:

• Cook County, Illinois: A consolidation of 145 cases is being managed by Judge Kathy M. Flanagan. Five cases may be scheduled for trial following a November 26 hearing.
• Other States: Georgia has 126 cases pending, followed by Pennsylvania (26), New York (4), and Delaware (1).

The litigation centers on uterine, endometrial, and ovarian cancers.

Studies reveal that women who regularly use hair relaxers face a 156% higher risk of uterine cancer.

Coordinated discovery and trials are designed to strengthen the foundation for future claims and settlement negotiations.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

An increasing number of women are suing hair relaxer manufacturers, alleging that these products have caused severe health issues, including uterine, ovarian, and endometrial cancers.

In response, the U.S. District Judge presiding over these cases has appointed a Federal Magistrate Judge to oversee discovery disputes and ensure the claims progress smoothly.

Throughout the upcoming year, case management conferences will focus on major issues, potentially leading to trial dates.

The hair relaxer litigation, which began in 2022, originated from a study linking hair relaxer chemicals to a 156% increase in uterine cancer risk.

To date, over 9,500 lawsuits have been filed against popular brands like Dark & Lovely and Just for Me, alleging that these companies failed to warn consumers of the risks associated with endocrine-disrupting chemicals in their products.

Judge Rowland has established firm discovery deadlines, requiring written discovery by February 2025 and oral discovery by September 2025.

Magistrate Judge Beth W. Jantz has been assigned to handle any disputes during discovery, though she cannot alter the deadlines.

Monthly case management conferences will run from November 2024 to December 2025 to monitor discovery progress.

Judge Rowland has also directed the parties to propose bellwether trial plans.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer lawsuit is ongoing. 

The Hair Relaxer Lawsuit continues to grow as more individuals file claims alleging that hair relaxers and straighteners contain carcinogenic chemicals linked to cancer.

Plaintiffs argue that manufacturers failed to adequately warn consumers about these cancer risks, despite marketing these products heavily to women of color.

As of October, there were 8,393 active cases in the Hair Relaxer and Hair Straightener lawsuit.

By November, this number had surged to 9,488, reflecting an increase of 1,095 new filings.

Hair relaxers and straighteners often contain endocrine-disrupting chemicals associated with hormone-related cancers, presenting serious health risks for individuals using these products regularly over time.

If you or a loved one used chemical hair relaxers or straighteners and subsequently developed cancer or other health complications, you may be eligible to file a Hair Straightener Lawsuit. 

Contact TruLaw for a free consultation or use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit is ongoing. 

As the number of Hair Relaxer Lawsuits continues to grow, the federal court overseeing the litigation has extended the discovery timeline into late 2025.

The current schedule includes written discovery to be completed by February 28, 2025, and oral discovery set to finish by September 30, 2025.

The litigation, centralized under the U.S. District Judge Mary Rowland in the Northern District of Illinois, addresses claims that popular hair relaxer products, such as Dark & Lovely and Just for Me, may cause uterine cancer, endometrial cancer, and ovarian cancer.

There are currently around 8,400 lawsuits pending in the Hair Relaxer MDL.

Plaintiffs allege that manufacturers failed to adequately warn consumers about the cancer risks associated with regular use of these chemical hair straighteners.

These lawsuits gained traction after a 2022 study revealed a 156% increased risk of uterine cancer for women who frequently used hair relaxers.

In November 2023, Judge Rowland ordered both parties to submit trial plans for selecting bellwether cases, which will help gauge how juries might respond to these claims.

While the parties have not yet agreed on the details of the trial process, the first cases are expected to go before juries in 2026 or later.

The outcome of these trials could significantly impact potential settlement negotiations, possibly resulting in settlements for women diagnosed with cancer after using these products.

If you or a loved one used chemical hair straighteners and developed cancer or other health problems, you may be eligible to file a Hair Relaxer Lawsuit. 

Contact TruLaw’s Hair Relaxer Lawyers for a free consultation. 

You can also use the chatbot on this page to find out if you qualify to file a Hair Relaxer Cancer Lawsuit instantly and connect with our Hair Relaxer Attorneys.

The Hair Relaxer Lawsuit is ongoing.

The Hair Straightener Cancer Lawsuit focuses on claims that chemicals used in hair relaxers and straighteners contain carcinogenic ingredients linked to an increased risk of certain cancers, including uterine and breast cancer.

Plaintiffs allege that manufacturers failed to warn consumers, particularly women of color, about the potential cancer risks associated with long-term use of these products.

In September, there were 8,489 cases filed in the Hair Relaxer MDL.

By October, the total number of cases had decreased to 8,393, reflecting a reduction of 96 filings.

This decrease may be due to the court’s decision not to allow certain diagnoses and medical monitoring cases to proceed within the litigation.

In August, plaintiff’s attorneys requested that the court dismiss, without prejudice, all cases with non-cancer injuries

Hair relaxers often contain chemicals like formaldehyde and endocrine-disrupting substances, which have been shown to affect hormone levels, potentially contributing to cancer development.

Studies indicate that frequent exposure to these chemicals increases the risk of hormone-related cancers, highlighting the significance of this lawsuit for the many women who have used these products over time.

If you or a loved one used chemical hair straighteners and developed cancer or uterine fibroids, you may be eligible to file a Hair Relaxer Lawsuit.

Contact TruLaw’s Hair Relaxer Lawyers for a free consultation.

The Hair Relaxer lawsuit is ongoing.

The Hair Relaxer multidistrict litigation (MDL), consolidating over 8,500 cases, has narrowed its focus to claims related to ovarian, uterine, and endometrial cancers.

In a rare move for mass tort cases, the plaintiff leadership has proactively sought to dismiss hundreds of unrelated claims to streamline the process.

Despite these developments, concerns remain that defendants are causing significant delays by withholding key documents necessary to complete general discovery.

These delays are slowing the progress of the litigation, leaving plaintiffs waiting for the resolution.

If you or a loved one has been affected, contact TruLaw for a free consultation. 

You can also use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly. 

The Hair Relaxer Litigation has seen a significant rise in case filings, increasing from 7,946 in August to 8,489 in September.

Research indicates that certain chemicals in hair relaxers and straighteners, including formaldehyde and other endocrine-disrupting compounds, may elevate the risk of developing cancers such as uterine and breast cancer.

These chemicals can disrupt the body’s hormonal balance by mimicking or blocking natural hormones, which interferes with normal hormonal functions.

This disruption can lead to abnormal cell growth in hormone-sensitive tissues like the uterus and breasts, potentially resulting in cancerous tumors over time.

Formaldehyde, in particular, is a well-known carcinogen linked directly to cancer in humans.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

Two U.S. Representatives, Ayanna Pressley from Massachusetts and Shontel Brown from Ohio, are urging the Food and Drug Administration (FDA) to explain the delay in proposing a ban on certain hair-straightening products that contain formaldehyde, a chemical linked to increased cancer risks.

They are joined by Rep. Nydia Velazquez of New York, who co-signed a letter to FDA Commissioner Robert Califf seeking clarity on the matter.

This letter follows the FDA’s 2023 announcement of a potential rule to ban these chemicals, which are predominantly used in products marketed to Black women.

The rule’s target date has been repeatedly postponed, shifting from April to July, and now to September, prompting the Congresswomen to demand an explanation for the delay.

Pressley highlighted that this delay could exacerbate health risks for communities of color, particularly Black women, who have long suffered from health issues related to hair straighteners.

This regulatory uncertainty coincides with the filing of thousands of lawsuits against beauty companies.

These lawsuits allege that the use of these products has increased the risk of uterine and ovarian cancers and caused infertility, and that manufacturers misrepresented the health risks, failing to warn consumers about the harmful chemicals adequately.

Studies from the National Institutes of Health in 2022 and Boston University in 2023 have both found significant links between the use of chemical hair straighteners and an elevated risk of uterine cancer.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Relaxer Lawsuit is ongoing. 

The Hair Relaxer Cancer Lawsuit involves claims against manufacturers of chemical hair straighteners and relaxers.

Plaintiffs assert that these products cause cancers such as uterine and breast cancer due to harmful chemicals.

In July, there were 8,192 pending filings in the Hair Relaxer Cancer lawsuit, which decreased to 7,946 by August.

This reduction is likely due to certain injury claims no longer being accepted or the identification of duplicate cases.

The short form complaint, introduced this year, allows plaintiffs to file directly into the MDL, bypassing state courts.

This change may have led to some plaintiffs unintentionally creating duplicate cases.

Chemical hair straighteners and relaxers contain ingredients linked to an increased risk of cancers like uterine and breast cancer, as these chemicals can disrupt hormonal balances and contribute to the development of cancerous cells, leading many individuals to pursue legal action against the manufacturers.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Relaxer Lawsuit is ongoing. 

The US Food and Drug Administration (FDA) has failed to implement its planned ban on formaldehyde in hair relaxer products, missing its own April deadline.

This delay comes amid thousands of lawsuits claiming that hair relaxer products containing formaldehyde have caused cancer and other serious health concerns.

These lawsuits allege that popular hair relaxer products have led to cancer, particularly targeting women who used these products.

Plaintiffs’ lawyers for those suffering from the negative health effects of hair relaxer products expressed disappointment at the FDA’s delay.

According to a statement from the FDA, the proposed rule to ban formaldehyde remains a high priority and is still in the rulemaking process.

The FDA cited the need for thorough risk assessments, literature reviews, and inter-agency approvals as reasons for the delay.

The FDA’s semiannual agenda of upcoming regulations, which includes the proposed formaldehyde ban, outlines these steps.

As the litigation progresses, plaintiffs and their attorneys hope for stricter regulations and greater accountability in the production and marketing of hair relaxer products.

You may be eligible to file a claim if you or a loved one used chemical hair straighteners, hair relaxers, or other similar hair products and subsequently were diagnosed with uterine cancer, endometrial cancer, breast cancer, or other health conditions.

Contact TruLaw for a free consultation, or use the chatbot on this page to see if you qualify to file a Hair Straightener Lawsuit instantly.

The Hair Relaxer Lawsuit is ongoing. 

Hair relaxer lawsuits highlight significant health risks, particularly affecting Black women.

Research by Dr. Tamarra James-Todd of Harvard reveals that chemicals in hair relaxers cause reproductive disorders and cancers.

These products contain endocrine-disrupting substances linked to early menstruation, uterine fibroids, preterm birth, infertility, and cancers.

Black women face a 28 percent higher breast cancer death rate than White women due to these issues.

Despite the known dangers, hair relaxers remain inadequately regulated by the FDA.

Many products contain banned substances like formaldehyde, and 84 percent of toxic ingredients are not listed on packaging, leaving consumers unprotected.

Lawsuits allege that manufacturers prioritize profits over safety, marketing dangerous products without proper warnings.

If you’ve suffered adverse health effects due to hair relaxer products, contact TruLaw today for a no-obligation consultation.

Our team will connect you with a dedicated Hair Relaxer Attorney within our network of legal partners to provide you with the strongest legal representation for your claim.

We are fully committed to securing the compensation you deserve.

The Hair Relaxer Lawsuit is ongoing.

The Hair Straightener lawsuit involves claims that certain hair straightening products contain harmful chemicals linked to cancer.

This lawsuit seeks to hold manufacturers accountable for the health risks associated with these products.

In June, there were 8,170 Hair Straightener lawsuit filings.

By July, this number increased to 8,192.

Hair straighteners contain toxic chemicals that can cause cancer by disrupting hormonal functions and damaging cellular DNA.

Prolonged exposure to these chemicals has led to serious health issues, prompting more individuals to join the Hair Straightener lawsuit.

The Hair Straightener lawsuit aims to hold manufacturers responsible for the harm caused by these dangerous products.

Affected individuals should consult a Hair Straightener lawsuit lawyer.

If you think your uterine cancer was caused by frequent exposure to hair-relaxing products, you deserve a chance to hold the manufacturer accountable for their negligence.

Contact TruLaw for a free, no-risk consultation to find out whether you have a case.

The Hair Relaxer Lawsuit is ongoing. 

In February 2023, a federal judge consolidated thousands of individual lawsuits into a single multidistrict litigation addressing the harmful health effects linked to chemical hair relaxers.

The 2022 Sister Study, conducted by the National Institute of Environmental Health Sciences, found a clear association between regular use of hair straightening chemicals and an elevated risk of uterine cancer.

The lawsuits allege that manufacturers failed to ensure the safety of these products, which contain chemicals known to disrupt endocrine function.

These chemicals are implicated in serious reproductive health issues such as early puberty, infertility, and various cancers, disproportionately impacting Black women.

Despite these significant risks, regulation of these products in the United States remains minimal, especially compared to the more stringent measures in the European Union.

The creation of this multidistrict litigation is intended to streamline proceedings by combining cases with similar factual questions about the health risks associated with chemical hair relaxers.

If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit is ongoing. 

The Hair Relaxer lawsuit alleges that chemical hair straightening products are linked to various cancer types.

The number of cases in the Hair Relaxer MDL has seen a decrease from 8,468 in May to 8,170 in June, a reduction of 298 cases.

This drop may reflect plaintiffs’ decisions to withdraw claims related to non-cancer injuries, thereby concentrating the litigation on cancer-specific allegations.

Studies suggest that chemicals in hair relaxers, absorbed through the scalp, may heighten the risk of cancers, including uterine and breast cancers.

Extended use of chemical hair relaxers, particularly over many years, is associated with an increased risk of uterine cancer, especially among postmenopausal women.

Women who frequently used these products (at least 5 times per year for over 15 years) exhibited a notably higher incidence of uterine cancer compared to less frequent users.

This link is even more pronounced among those who have used the products for 20 years or more, irrespective of usage frequency.

Individuals who have used hair relaxers and subsequently developed cancer should consider consulting with attorneys who specialize in Hair Relaxer cancer lawsuits.

If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Lawsuit is ongoing. 

According to Case Management Order No. 11, plaintiffs are mandated to file their Short Form Complaints and Plaintiff Fact Sheets through a designated electronic database overseen by a third-party administrator.

This system centralizes the management of documents, ensuring all relevant parties have prompt access to essential records.

It also serves to monitor submission timelines and deadlines.

Participants in the lawsuit are required to upload their documents and maintain updated case details within the platform by specified deadlines.

It is crucial for plaintiffs to keep their contact information current within the system to receive automatic alerts when documents are due.

The court has established specific protocols for addressing letters and correcting any deficiencies in submissions.

All information entered into the platform is managed with high security, following strict guidelines for data access and modification.

If you or a loved one has developed cancer or other health problems after using Hair Relaxer products, you may be eligible to file a claim. 

Contact us for a free consultation, or use the chatbot on this page to find out if you qualify for the Hair Straightener Lawsuit.

The Hair Relaxer Lawsuit continues to progress. 

The Food and Drug Administration (FDA) missed its own April 2024 deadline to release a proposal to ban formaldehyde in hair-straightening products.

Formaldehyde and similar chemicals in these products are linked to cancer risks.

Research, including a National Institutes of Health study of over 33,000 Black women, indicates a correlation between regular use of hair relaxers and increased uterine cancer risk.

Affected women have filed lawsuits against major cosmetic companies like L’Oreal and Revlon, though Revlon has previously stated there is no scientific support linking hair straighteners to cancer.

L’Oreal asserts its products do not contain formaldehyde yet supports the FDA’s proposed ban.

The Environmental Working Group has repeatedly petitioned the FDA to ban formaldehyde in hair products since 2011.

If you or a loved one regularly used Hair Relaxers, chemical hair straighteners, or other related products and have been diagnosed with cancer or other health problems, call us today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

The Hair Relaxer Multidistrict Litigation (MDL) continues to progress. According to the latest filings, 8,468 cases are currently pending.

In the past month, 81 new cases have been added to the MDL.

The lawsuits allege that the manufacturers of hair relaxer products failed to inform users about the risks associated with exposure to harmful chemicals present in these products, including a heightened risk of developing cancers such as uterine, ovarian, or breast cancer.

Individuals who developed cancer or other health issues after extended use of hair relaxers, hair straighteners, or similar products might be eligible to participate in the Hair Relaxer Lawsuit.

The Hair Relaxer Lawsuit is currently active. 

The Food and Drug Administration (FDA) is considering a proposal to ban certain chemicals found in hair relaxers due to emerging evidence that these chemicals may pose cancer risks.

This proposed ban would affect hair relaxers containing formaldehyde and similar substances, which have been linked to higher risks of respiratory tract cancers and myeloid leukemias.

These products are also known to include phthalates and other chemicals that disrupt hormonal functions, potentially contributing to cancer development.

In response to these findings, legal actions have already commenced, with lawsuits filed against various manufacturers of hair straighteners and relaxers, including the major company L’Oréal.

Our law firm is actively taking on new clients for the Hair Relaxer Lawsuit. 

Contact us today for a complimentary consultation, or use the chatbot on this page to immediately check if you are eligible to join the Hair Relaxer Lawsuit.

The Hair Relaxer Lawsuit is actively progressing.

The recent filings to the Judicial Panel on Multidistrict Litigation (JPML) showing an increase in the number of lawsuits to 8,380 a significant rise from the 8,334 reported as of March 1st.

These lawsuits have been initiated by individuals who claim to have suffered adverse health effects, including cancer, after using hair relaxer products.

The litigation centers around allegations that manufacturers did not properly inform consumers about the potential health risks of chemicals in hair relaxers.

The primary concern is that certain chemicals may contribute to the development of various health conditions.

Plaintiffs are seeking compensation for damages resulting from the use of these products.

For those who have used hair relaxers and are now experiencing health issues, legal recourse may be an option worth exploring.

Eligibility for participation in the Hair Relaxer Lawsuit can be found through by using the chatbot feature on their website.

The lawsuit concerning hair relaxers continues to progress.

According to the latest filings by the Judicial Panel on Multidistrict Litigation (JPML), an additional 117 cases were incorporated into the Hair Relaxer Multidistrict Litigation (MDL) during February.

The JPML had previously reported a consolidation of 8,217 Hair Relaxer Lawsuits within the MDL as of February, with the numbers increasing to 8,334 by March 1st.

These lawsuits target several manufacturers, including L’Oreal, Softsheen-Carson (Optimum Relaxer), Dark & Lovely, Just For Me, Motions Hair, ORS Hair Care (Namaste Laboratories, LLC), and African Pride (Godrej Group), alleging that their hair relaxer products contain harmful chemicals that may significantly elevate the risk of various cancers.

Individuals who believe they or their loved ones have suffered health issues as a result of using these hair relaxers are encouraged to explore their legal options.

For immediate support and to find out if you qualify for the lawsuit, please utilize the chatbot feature available on this page.

The Hair Relaxer Lawsuit is ongoing.

A recent study explored the link between the usage of chemical hair relaxers, which are commonly utilized by Black women in the United States, and the likelihood of developing uterine cancer.

The investigation tracked a cohort of 44,798 Black women from 1997 to 2019 and revealed that extensive use of hair relaxers (lasting 15 years or more, at a minimum of 5 times annually) was associated with a slightly elevated risk of uterine cancer.

To be more specific, among postmenopausal women, both moderate and heavy use of hair relaxers, as well as a duration of over 20 years of use regardless of frequency, demonstrated a heightened risk of uterine cancer.

There was no statistically significant connection found between the use of hair relaxers and the risk of uterine cancer among premenopausal women.

These findings imply that prolonged use of chemical hair relaxers could potentially be a risk factor for uterine cancer, especially among postmenopausal Black women.

In November 2023, the hair relaxer lawsuit saw significant developments.

The Plaintiff’s Leadership Committee (PLC) formally filed a status update with the Court, marking an essential step forward in this high-profile case.

Meanwhile, the number of pending lawsuits in the Illinois Multi-District Litigation (MDL) has surged to approximately 5,996.

As legal proceedings continue to intensify, we eagerly anticipate a ruling from the centralizing board on whether these individual cases will be condensed into a new class action lawsuit.

This litigation milestone could have substantial implications for all involved parties and create a precedent for future chemical hair product disputes.

A federal judge, specifically U.S. District Judge Mary Rowland in Illinois, has permitted the majority of claims to proceed in a significant lawsuit alleging that chemical hair relaxer products produced by companies like L’Oreal USA and Revlon are the cause of cancer and other harm.

Judge Rowland rejected most of the companies’ contentions in their bid to dismiss the complaint within the multidistrict litigation, which encompasses over 8,000 lawsuits.

She determined that the plaintiffs had offered ample evidence to substantiate their accusations, which encompass claims of negligence, defective product design, and a failure to adequately caution customers about potential risks.

Of the 15 claims contained in the complaint, Rowland dismissed three entirely and a part of a fourth due to insufficient backing for the plaintiffs’ assertions of fraud.

These hair relaxer products, primarily marketed to women of color, include chemicals for permanently straightening textured hair.

Legal actions were instigated following a National Institutes of Health study published in October 2022, which found that women who used these products multiple times a year were more than twice as likely to develop uterine cancer.

While L’Oreal had previously expressed confidence in the safety of its products, and Revlon stated its disbelief in the existence of scientific evidence linking chemical hair straighteners or relaxers to cancer, smaller cosmetics companies, including some headquartered in India, are also implicated in the lawsuits.

One of the lead attorneys representing the consumers declared that the court’s decision supports their contention that the products and the instructions provided by the companies are responsible for causing cancer.

The Plaintiff’s Steering Committee is pushing for an 11% set-aside from the total settlement or judgment in each case.

This split comprises 8% for work that benefits all parties involved and 3% for covering common benefit costs.

The motion also highlights unanimous support within the committee.

Nonetheless, these attorney fee percentages won’t impact victims’ compensation.

The primary focus remains on maximizing settlements for victims, which appears to be progressing effectively.

The Food and Drug Administration (FDA) is suggesting a prohibition on the inclusion of formaldehyde as an ingredient in hair relaxers, particularly in products designed for hair-smoothing and hair-straightening, which are commonly used by Black women.

Formaldehyde is a hazardous substance capable of causing irritation to the eyes, skin, lungs, and throat and has been associated with specific cancers, including myeloid leukemia.

The current FDA regulations do not mandate the pre-market approval of cosmetic products and their components, sparking concerns about the safety of these products.

Recent studies have illuminated the potential risks associated with chemical hair relaxers, revealing a heightened likelihood of uterine cancer among women who use such products.

Hair relaxers often contain endocrine disruptors that can disrupt the body’s hormone system, leading to a range of health issues, such as early puberty, fibroid tumors, infertility, and reduced fertility in women.

The FDA’s proposed prohibition follows concerns raised by congressional representatives and advocates regarding the safety of these products, particularly among Black women.

The intended date for implementing the ban is set for April.

Moreover, policies like the CROWN Act, which bars discrimination based on hair texture, have been gaining traction in numerous states to address concerns surrounding hair and societal norms.

Judge Rowland recently issued Case Management Order No. 9 (CMO 9) to address the rapid increase in hair relaxer class action lawsuits.

This order establishes guidelines for the filing and handling of short-form complaints (SFC) by the numerous new plaintiffs participating in the MDL.

The surge in new chemical hair straightener lawsuits can be attributed to a bankruptcy judge’s order related to Revlon. This order mandates lawyers to file lawsuits in order to safeguard their claims against Revlon.

The first hair relaxer lawsuit was filed on October 21, 2022.

This lawsuit was significant because it was the first to legally challenge the safety of hair relaxers.

Key details of the lawsuit include:

• The lawsuit was filed against cosmetic companies.
• It was based on the scientific evidence linking hair relaxer usage and cancer risk.
• The lawsuit sought compensation for individuals who had developed cancer after using hair relaxers.

This lawsuit marked the beginning of legal action against manufacturers of hair relaxers.

The first hair relaxer lawsuit had a significant impact.

It brought the issue of hair relaxer safety to the forefront and paved the way for further legal actions.

The impact of the lawsuit can be seen in several areas:

• It raised public awareness about the potential risks of using hair relaxers.
• It prompted further research into the safety of hair relaxers.
• It led to more lawsuits being filed against hair relaxer manufacturers.

In the past three months, an additional 2,000 cases have joined the hair relaxer class action lawsuit.

At this rate, it is projected that the MDL will exceed 4,000 cases by the end of the year.

There is anticipation that this trend will persist and possibly even lead to the hair relaxer MDL becoming as large as the talcum powder MDL.

Throughout the past month, several noteworthy developments have come forth.

During a recent status conference presided over by Judge Rowland, a firm deadline of August 30, 2023, has been established for the submission of a joint written status report concerning the dismissal motions related to McBride, the defendant.

There was also debate at the conference regarding Federal Rule 26(a)(1) and 30 (b)(6), which involve expert witnesses and company testimonials.

Both parties were arguing that the other’s witness selection and testimonial strategies did not align with one of the federal statutes.

Additionally, Dabur International, the parent company of Namaste Laboratories and a prominent defendant in the hair relaxer lawsuit, switched its legal counsel from Kirkland & Ellis LLC with new attorneys from Baker & McKenzie LLP.

Earlier this month, Dermoviva Skin Essentials Inc. was removed from the class action, however, the possibility of its reinstatement is still under consideration.

Judge Rowland has slated a discovery hearing for October 2nd, 2023.

A woman from Brooklyn, Minnesota, has become a recent addition to the hair relaxer class action MDL.

The lawsuit alleges that between 1985 and 2011, the plaintiff used three chemical hair relaxer products: ORS Olive Oil, Just for Me, and S&B Botanicals.

In 2019, the plaintiff was diagnosed with endometrial cancer, which she attributes to the use of these hair relaxer products.

New hair relaxer cancer lawsuits can now be submitted directly to the class action MDL using an approved Short Form Complaint, as authorized by Judge Rowland.

This new process is expected to streamline and expedite the filing of such lawsuits, potentially resulting in a higher number of new filings in the MDL.

30 new cases have been added to the hair relaxer class action MDL over the previous month, bringing the total number of pending cases to 275.

New hair relaxer cancer lawsuits can now be submitted directly to the class action MDL using an approved Short Form Complaint, as authorized by Judge Rowland.

This new process is expected to streamline and expedite the filing of such lawsuits, potentially resulting in a higher number of new filings in the MDL.

The MDL saw a significant increase in hair relaxer cancer lawsuits last month, with 87 new cases added, marking the highest monthly total since the start of the MDL.

This surge continues a steady upward trend in new case filings observed over the past four months.

In February, there were only 21 pending cases in the MDL, but currently, there are 236 pending cases.

Revlon provided an update on their ongoing bankruptcy proceedings and responded to the plaintiffs’ status report, submitted on June 30, 2023, before the MDL judge.

Despite being in bankruptcy, the significance of Revlon’s case lies in its possession of a substantial insurance policy to cover hair relaxer cancer lawsuits.

The company is responsible for various hair relaxer brands, including Crème of Nature, African Pride, French Perm, Fabulaxer, Revlon Professional, Revlon Realistic, Herbarich, and All Ways Natural Relaxer.

Attorneys representing victims in federal hair relaxer lawsuits are urging the Court to reject a proposal by the product manufacturers to divide the discovery process, citing concerns about potential lengthy delays in the litigation.

Manufacturers of hair relaxer products, in response to mounting lawsuits, have requested the court to bifurcate discovery.

This would limit discovery to general causation information on the link between hair relaxers and cancer while staying all other discovery related to manufacturers’ liability, awareness of risks, and extent of damages.

In a brief submitted on June 5th, plaintiffs underscored bifurcation’s potential to cause substantial delays in the litigation process, escalate costs significantly, and its track record of being “incredibly inefficient” in achieving a resolution or settlement.